Market Forecast By Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Type (Monovalent Vaccines, Multivalent Vaccines), By Disease Indication (Pneumococcal Disease, DTP, Influenza, HPV, Meningococcal Disease, Polio, Rotavirus, Other Disease Indications), By Route Of Administration (Intramuscular And Subcutaneous Administration, Oral Administration, Other Routes Of Administration), By Patient Type (Pediatric Patients, Adult Patients) And Competitive Landscape
Product Code: ETC150134 | Publication Date: Nov 2021 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
Key Highlights of the Report:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Vaccines Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Vaccines Market Revenues & Volume, 2020 & 2027F |
3.3 Global Vaccines Market - Industry Life Cycle |
3.4 Global Vaccines Market - Porter's Five Forces |
3.5 Global Vaccines Market Revenues & Volume Share, By Regions, 2020 & 2027F |
3.6 Global Vaccines Market Revenues & Volume Share, By Technology, 2020 & 2027F |
3.7 Global Vaccines Market Revenues & Volume Share, By Type, 2020 & 2027F |
3.8 Global Vaccines Market Revenues & Volume Share, By Disease Indication, 2020 & 2027F |
3.9 Global Vaccines Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
3.10 Global Vaccines Market Revenues & Volume Share, By Patient Type, 2020 & 2027F |
4 Global Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Vaccines Market Trends |
6 Global Vaccines Market, 2017 - 2027 |
6.1 Global Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
6.2 Global Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
6.3 Global Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
6.4 Global Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
6.5 Global Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
7 North America Vaccines Market, 2017 - 2027 |
7.1 North America Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
7.2 North America Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
7.3 North America Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
7.4 North America Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
7.5 North America Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
8 Latin America Vaccines Market, 2017 - 2027 |
8.1 Latin America Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
8.2 Latin America Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
8.3 Latin America Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
8.4 Latin America Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
8.5 Latin America Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
9 Europe Vaccines Market, 2017 - 2027 |
9.1 Europe Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
9.2 Europe Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
9.3 Europe Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
9.4 Europe Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
9.5 Europe Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
10 Asia Pacific Vaccines Market, 2017 - 2027 |
10.1 Asia Pacific Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
10.2 Asia Pacific Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
10.3 Asia Pacific Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
10.4 Asia Pacific Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
10.5 Asia Pacific Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
11 Middle East Vaccines Market, 2017 - 2027 |
11.1 Middle East Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
11.2 Middle East Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
11.3 Middle East Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
11.4 Middle East Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
11.5 Middle East Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
12 Africa Vaccines Market, 2017 - 2027 |
12.1 Africa Vaccines Market, Revenues & Volume, By Technology, 2017 - 2027 |
12.2 Africa Vaccines Market, Revenues & Volume, By Type, 2017 - 2027 |
12.3 Africa Vaccines Market, Revenues & Volume, By Disease Indication, 2017 - 2027 |
12.4 Africa Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
12.5 Africa Vaccines Market, Revenues & Volume, By Patient Type, 2017 - 2027 |
13 Global Vaccines Market Key Performance Indicators |
14 Global Vaccines Market - Opportunity Assessment |
14.1 Global Vaccines Market Opportunity Assessment, By Regions, 2020 & 2027F |
14.2 Global Vaccines Market Opportunity Assessment, By Technology, 2020 & 2027F |
14.3 Global Vaccines Market Opportunity Assessment, By Type, 2020 & 2027F |
14.4 Global Vaccines Market Opportunity Assessment, By Disease Indication, 2020 & 2027F |
14.5 Global Vaccines Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
14.6 Global Vaccines Market Opportunity Assessment, By Patient Type, 2020 & 2027F |
15 Global Vaccines Market - Competitive Landscape |
15.1 Global Vaccines Market Revenue Share, By Companies, 2020 |
15.2 Global Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
16 Company Profiles |
17 Recommendations |
18 Disclaimer |